IQVIA Holdings Inc: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über IQVIA Holdings Inc Unternehmen

IQVIA Holdings Inc. is a provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Its segments include Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. Technology & Analytics Solutions segment offers mission-critical information, technology solutions and real-world insights and services to its life science clients. Research & Development Solutions segment serves biopharmaceutical customers and provides outsourced clinical research and clinical trial related services. Contract Sales & Medical Solutions segment offers health care providers (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market. Its Connected Intelligence delivers insights and solutions enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients.

IQVIA Holdings Inc Informationen



BörsenkürzelIQV

Name des UnternehmensIQVIA Holdings Inc

IPO-datumMay 09, 2013

CEOMr. Ari Bousbib

Anzahl der mitarbeiter88000

WertpapierartOrdinary Share

GeschäftsjahresendeMay 09

Addresse2400 Ellis Road

StadtDURHAM

BörseNYSE Consolidated

LandUnited States of America

Postleitzahl27703

Telefon19199982000

Websitehttps://ir.iqvia.com/

BörsenkürzelIQV

IPO-datumMay 09, 2013

CEOMr. Ari Bousbib

Führungskräfte von IQVIA Holdings Inc



Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Ari Bousbib

Chairman of the Board, Chief Executive Officer

1.35M

--

Mr. Ronald E. (Ron) Bruehlman

Chief Financial Officer, Executive Vice President

46.46K

-1.91%

Mr. John G. Danhakl

Independent Director

30.85K

-79.16%

Mr. Eric M. Sherbet

Executive Vice President, General Counsel, Secretary

21.11K

--

Ms. Colleen A. Goggins

Independent Director

16.83K

+10.45%

Dr. John M. Leonard, M.D.

Lead Independent Director

15.38K

+11.55%

Ms. Carol J. Burt

Independent Director

7.01K

+17.56%

Mr. James A. Fasano

Independent Director

2.74K

+157.67%

Mr. John P. Connaughton

Independent Director

1.05K

--

Mr. Bhavik Patel

President, Commercial Solutions

863.00

-8.87%

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Ari Bousbib

Chairman of the Board, Chief Executive Officer

1.35M

--

Mr. Ronald E. (Ron) Bruehlman

Chief Financial Officer, Executive Vice President

46.46K

-1.91%

Mr. John G. Danhakl

Independent Director

30.85K

-79.16%

Mr. Eric M. Sherbet

Executive Vice President, General Counsel, Secretary

21.11K

--

Ms. Colleen A. Goggins

Independent Director

16.83K

+10.45%

Dr. John M. Leonard, M.D.

Lead Independent Director

15.38K

+11.55%

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

Keine Daten

Nach RegionUSD

Name

Umsatz

Anteil

Americas

1.94B

48.17%

Europe & Africa Region

1.24B

30.89%

Asia Pacific Region

841.00M

20.94%

Nach Geschäftsbereich

Nach Region

Keine Daten

Aktionärsstatistik

Aktualisiert: Fri, Oct 31

Aktionäre

Aktionärstypen

Aktionäre

Anteil

The Vanguard Group, Inc.

11.40%

Harris Associates L.P.

6.90%

BlackRock Institutional Trust Company, N.A.

5.50%

State Street Investment Management (US)

4.48%

GIC Private Limited

3.84%

Andere

67.88%

Aktionäre

Anteil

The Vanguard Group, Inc.

11.40%

Harris Associates L.P.

6.90%

BlackRock Institutional Trust Company, N.A.

5.50%

State Street Investment Management (US)

4.48%

GIC Private Limited

3.84%

Andere

67.88%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor

48.20%

Investment Advisor/Hedge Fund

34.87%

Hedge Fund

7.16%

Sovereign Wealth Fund

4.96%

Pension Fund

4.16%

Research Firm

2.49%

Bank and Trust

2.06%

Individual Investor

0.91%

Family Office

0.13%

Institutionelle Beteiligung



Aktualisiert: Wed, Oct 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q3

2061

175.98M

103.33%

-829.63K

2025Q2

2053

166.70M

98.05%

-9.45M

2025Q1

2083

168.53M

97.38%

-9.36M

2024Q4

2059

171.87M

97.45%

+3.00M

2024Q3

2008

173.01M

95.44%

+863.78K

2024Q2

1977

164.85M

90.43%

-7.68M

2024Q1

1950

165.50M

90.84%

-10.38M

2023Q4

1948

168.90M

93.03%

-6.38M

2023Q3

1925

170.01M

92.82%

-4.41M

2023Q2

1898

167.84M

91.62%

-8.26M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

The Vanguard Group, Inc.

19.60M

11.53%

-162.29K

-0.82%

Jun 30, 2025

Harris Associates L.P.

11.75M

6.91%

+583.80K

+5.23%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

9.37M

5.51%

-507.18K

-5.13%

Jun 30, 2025

State Street Investment Management (US)

7.62M

4.49%

-98.36K

-1.27%

Jun 30, 2025

GIC Private Limited

6.54M

3.85%

-2.59M

-28.36%

Mar 31, 2025

Geode Capital Management, L.L.C.

4.22M

2.48%

-16.90K

-0.40%

Jun 30, 2025

CPP Investments

4.17M

2.45%

-426.35K

-9.28%

Jun 30, 2025

Farallon Capital Management, L.L.C.

3.85M

2.27%

+439.50K

+12.88%

Jun 30, 2025

AllianceBernstein L.P.

3.56M

2.09%

+19.57K

+0.55%

Jun 30, 2025

Artisan Partners Limited Partnership

3.27M

1.93%

+3.27M

--

Jun 30, 2025

Verbundene ETFs



Aktualisiert: Thu, Nov 6

Name

Anteil

First Trust Nasdaq Lux Digi Health Solutions ETF

7.97%

Global X HealthTech ETF

5.5%

VanEck Biotech ETF

4.63%

Langar Global HealthTech ETF

4.46%

Adaptive Core ETF

3.04%

iShares Biotechnology ETF

3.03%

iShares ESG Aware MSCI USA Value ETF

2.37%

Invesco Bloomberg Pricing Power ETF

1.96%

American Century Focused Large Cap Value ETF

1.93%

Running Oak Efficient Growth ETF

1.87%

First Trust Nasdaq Lux Digi Health Solutions ETF

Anteil7.97%

Global X HealthTech ETF

Anteil5.5%

VanEck Biotech ETF

Anteil4.63%

Langar Global HealthTech ETF

Anteil4.46%

Adaptive Core ETF

Anteil3.04%

iShares Biotechnology ETF

Anteil3.03%

iShares ESG Aware MSCI USA Value ETF

Anteil2.37%

Invesco Bloomberg Pricing Power ETF

Anteil1.96%

American Century Focused Large Cap Value ETF

Anteil1.93%

Running Oak Efficient Growth ETF

Anteil1.87%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split



Datum

Art

Verhältnis

Keine Daten

Datum

Art

Verhältnis

Keine Daten